| AGIOS PHARMACEUT. DL-,001 |
| USA |
| Gesundheit |
| US00847X1046 / A1W2RM |
| 8AP (Frankfurt) / AGIO (NASDAQ) |
| FRA:8AP, ETR:8AP, 8AP:GR, NASDAQ:AGIO |
| - |
| https://www.agios.com/ |
|
Agios Pharmaceuticals Inc. is a biopharmaceutical ..
>Volltext.. |
| 2270.92 Mio. EUR |
| 1496.77 Mio. EUR |
| 38.65 Mio. EUR |
| -405.84 Mio. EUR |
| -346.26 Mio. EUR |
| -6 EUR |
| 38.41 Mio. EUR |
| 80 Mio. EUR |
| -353.73 Mio. EUR |
| 12.75 |
| 29.29% |
| -156.46% |
| - |
| - |
| - |
| AGIOS |
| 19.11.25 |